Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)

World News: . []

BOSTON and LONDON Sept 04 2019 GLOBE LINK  -- Orchard Therapeutics Nasdaq ORTX a LINK  commercial-stage biopharmaceutical company dedicated to transforming the lives of LINK  with serious and life-threatening rare diseases LINK  innova...

More news and information about Orchard Therapeutics

Published By:

Globe Newswire: 12:05 GMT Wednesday 4th September 2019

Published: .

Search for other references to "orchard" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us